Laparoscopic mesh-augmented hiatoplasty as a treatment of gastroesophageal reflux disease and hiatal hernias–preliminary clinical and functional results of a prospective case series
Abstract
Background
Because fundoplication-related side effects are frequent, we evaluated laparoscopic mesh-augemented hiatoplasty (LMAH) as a potential treatment option for gastroesophageal reflux disease and/or symptomatic hiatal herania. LMAH aims to prevent reflux solely by mesh-reinforced narrowing of the hiatus and lengthening of the intra-abdominal esophagus.
Methods
Twenty-two consecutive patients with LMAH were evaluated prospectively using a modified Gastrointestinal Symptom Rating Scale questionnaire, pH measurement, manometry, and endoscopy. Follow-up was scheduled at 3 and 12 months after surgery.
Results
Total reflux decreased from 16.3% before surgery to 3.5% 3 months after surgery (P = .001). The reflux score decreased from 3.8 before surgery to 2.1 1 year after surgery (P = .001). The respective values of the indigestion score were 3.4 and 2.0 (P < .001). After surgery, all patients were able to belch. Vomiting was impossible only for 2 patients, and 90% of patients assessed their results as good to excellent.
Conclusions
LMAH seems to be feasible, safe, and has no significant side effects.
Keywords: Antireflux surgery, Gastroesophageal reflux disease, Hiatal hernia, Laparoscopic fundoplication, Laparoscopic mesh-augmented hiatoplasty, Mesh reinforcement
To access this article, please choose from the options below
PII: S0002-9610(08)00004-4
doi:10.1016/j.amjsurg.2007.06.022
© 2008 Elsevier Inc. All rights reserved.
